-+ 0.00%
-+ 0.00%
-+ 0.00%

COGENT BIOSCIENCES - FDA DOES NOT PLAN ADVISORY COMMITTEE OR IDENTIFY REVIEW ISSUES FOR NDA

Reuters·05/28/2026 12:00:07

Please log in to view news